Refine by
Tumor Specificity Articles & Analysis: Older
35 articles found
Staining techniques, such as hematoxylin and eosin (H&E), provide essential insights into the tumor architecture and cellular morphology. Additionally, immunohistochemical staining can elucidate the expression of specific biomarkers, aiding in the differentiation of cancer subtypes and informing treatment decisions. ...
The Importance of Kinase Screening Kinases are implicated in a myriad of diseases, particularly cancer, where their dysregulation leads to uncontrolled cell proliferation. Targeting specific kinases has become a promising strategy for developing more effective and selective cancer therapies. ...
The firm develops monoclonal antibodies that target tumor-specific antigens through the services. This method shows potential for better patient response rates while simultaneously enabling the detection of tumor progression and resistance mechanisms. ...
Unlike traditional cancer therapies that often target the tumor directly, these services aim to empower the immune system to recognize and attack cancer more effectively. ...
Researchers use these models because they retain many of the biological properties of the original tumors, thus providing insights into the cancer’s behavior. The establishment of cell lines involves extracting cancer cells from a tumor biopsy, followed by their growth in a nutrient-rich medium under sterile conditions. ...
Picture enzymes as the master choreographers, each with a specific role to ensure the mRNA production process runs smoothly. Let me introduce you to the key players: RNA Polymerase: The Architect RNA polymerase is the cornerstone enzyme for mRNA transcription. ...
Zebrafish and mammals share common molecular pathways for tumor progression. Likewise, more than 130 different genes in zebrafish liver tumors exhibited expression similar to those characteristic of human liver cancers, correlating with histological tumor type, grade, and stage. ...
In the environment of cancer, antigens may be specific to tumor cells and are known as tumor-specific antigens (TSAs) or tumor-associated antigens (TAAs). ...
By analyzing the specific characteristics of individual tumor cells, researchers can identify unique cellular profiles that contribute to tumor growth and resistance to treatment. ...
Immunohistochemistry is the study of the localization, characterization, and relative quantification of peptides and proteins in tissue cells using the antigen-antibody reaction, in which an antigen specifically binds to an antibody and a chemical reaction results in the visualization of dyes such as fluorescein and other chromogens, as well as enzymes, metal ions and isotopes, ...
Antibody-PROTAC conjugates combine the catalytic properties of PROTAC with the tissue specificity of ADC, thereby overcoming the traditional limitations of targeting degraders and ADCs, and have great potential in targeting new targets.ADC with NIR-PIT Drug as PayloadNear-infrared photoimmunotherapy (NIR-PIT) drugs typically consist of ...
Bispecific antibody conjugates (BsAb ADCs) are one of the emerging new technologies. The high specificity of bispecific antibodies enables more precise targeting of tumor cells. ...
Car-t cell therapy involves genetically engineering T cells isolated from patients or allogeneic donors to express chimeric antigen receptors (CAR) that specifically recognize and kill tumor cells. As a "living" drug, CAR-T therapy is very different from traditional drugs. It is a new type of precision targeted therapy for the treatment of ...
Although TMB shows potential as a biomarker for immunotherapy in solid tumors, consensus on the optimal TMB threshold for specific tumor types remains elusive. ...
Ideally, the antigen should be overexpressed on the surface of tumor cells and not expressed (or very low) in normal tissues. Lack of high specificity or cross-reaction with other antigens will cause unpredictable side effects and reduce the treatment window. ...
Structurally, an ADC consists of monoclonal antibodies (Antibody) that target specific antigens on tumor surfaces, cytotoxic drugs (drugs) that kill tumor cells, and linkers (Conjugate/ linkers) that conjugate cytotoxic drugs to antibodies. ...
Targets can be divided into tumor-specific antigens (TSA) and tumor-associated antigens (TAA) according to their expression. Antigens that are only expressed in tumor cells but not in normal cells are tumor-specific antigens and the most ideal targets; antigens that are lowly expressed in normal ...
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. ...
The aim of the project was to develop a Polish complementary system of molecular surgical navigation for the treatment of ...
Additionally, these tests are highly sensitive and specific, meaning that they can accurately detect even small amounts of a particular enzyme or protein. ...